Salam, Alex
154  results:
Search for persons X
?
 
?
2

An open-label, randomized, non-inferiority trial of the eff..:

Randremanana, Rindra Vatosoa ; Raberahona, Mihaja ; Randria, Mamy Jean de Dieu...
https://researchonline.lshtm.ac.uk/id/eprint/4659650/1/An%20open-label,%20randomized,%20non-inferiority%20trial%20of%20the%20efficacy%20and%20safety%20of%20ciprofloxacin%20versus%20streptomycin%20%2B%20ciproflox.pdf.  , 2020
 
?
4

Phase 2a, open-label, dose-escalating, multi-center pharmac..:

Wang, Yeming ; Zhong, Wu ; Salam, Alex...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689521/.  , 2020
 
?
 
?
 
?
11

Lack of Evidence for Ribavirin Treatment of Lassa Fever in ..:

Cheng, Hung-Yuan ; French, Clare E ; Salam, Alex P...
Cheng , H-Y , French , C E , Salam , A P , Dawson , S , McAleenan , A , McGuinness , L A , Savović , J , Horby , P W & Sterne , J A C 2022 , ' Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies ' , Emerging Infectious Diseases , vol. 28 , no. 8 , pp. 1559-1568 . https://doi.org/10.3201/eid2808.211787.  , 2022
 
?
13

Ribavarin for treating Lassa fever: A systematic review of ..:

Salam, Alex P ; Duvignaud, Alexandre ; Jaspard, Marie...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pntd.0010289.  , 2022
 
?
14

Ribavarin for treating Lassa fever: A systematic review of ..:

Salam, Alex P ; Duvignaud, Alexandre ; Jaspard, Marie...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pntd.0010289.  , 2022
 
?
15

Lassa fever outcomes and prognostic factors in Nigeria (LAS..:

Duvignaud, Alexandre ; Jaspard, Marie ; ETAFO, Ijeoma Chukwudumebi...
info:eu-repo/semantics/altIdentifier/doi/10.1016/s2214-109x(20)30518-0.  , 2021
 
1-15